Active	Status	Sponsor type	Region	Phase	Filter
11 Active 5 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Hao
TQB2102-II-03, NCT06496490: A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality	Recruiting	2	270	RoW	TQB2102 for injection, TQB2102 for injection combined with Benmelstobart injection	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Non-Small Cell Lung Cancer	10/25	02/26
NCT04592315: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients	Completed	1	46	RoW	Lipovirtide Injection	Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences	HIV Infections	05/23	07/23
NCT05349968: Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients	Completed	1	24	RoW	Lipovirtide for injection, nothing	Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences	HIV Infections	06/23	09/23
Wang, Xiuling
No trials found